Silencing of farnesoid X receptor in human colon cancer by epigenetic mechanisms is associated with cancer progression.

被引：0
|
作者：
Thomas, Ann M. [1 ]
Zhan, Le [2 ]
Izzo, Julie [1 ]
Maru, Dipen [1 ]
Shureiqi, Imad [1 ]
Baladandayuthapani, Veera [1 ]
Liang, Han [1 ]
Guo, Grace L. [3 ]
Powis, Garth [1 ]
机构：
[1] UT MD Anderson Canc Ctr, Houston, TX USA
[2] Univ Kansas Med Ctr, Kansas City, KS USA
[3] Rutgers State Univ, Piscataway, NJ USA
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-3561
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3561
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Epigenetic Silencing of LMX1A Contributes to Cancer Progression in Lung Cancer Cells
    Wu, Ti-Hui
    Chang, Shan-Yueh
    Shih, Yu-Lueng
    Chian, Chih-Feng
    Chang, Hung
    Lin, Ya-Wen
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (15) : 1 - 19
  • [22] Synergistic tumor inhibition of colon cancer cells by nitazoxanide and obeticholic acid, a farnesoid X receptor ligand
    Junhui Yu
    Kui Yang
    Jianbao Zheng
    Wei Zhao
    Xuejun Sun
    Cancer Gene Therapy, 2021, 28 : 590 - 601
  • [23] Effects and mechanism of the bile acid (farnesoid X) receptor on the Wnt/β-catenin signaling pathway in colon cancer
    Mao, Jiayu
    Chen, Xueqi
    Wang, Chunsaier
    Li, Wenbin
    Li, Jingnan
    ONCOLOGY LETTERS, 2020, 20 (01) : 337 - 345
  • [24] Synergistic tumor inhibition of colon cancer cells by nitazoxanide and obeticholic acid, a farnesoid X receptor ligand
    Yu, Junhui
    Yang, Kui
    Zheng, Jianbao
    Zhao, Wei
    Sun, Xuejun
    CANCER GENE THERAPY, 2021, 28 (06) : 590 - 601
  • [25] Epigenetic Mechanisms for Green Tea in Prevention of Colon Cancer
    Wargovich, M. J.
    Morris, J.
    Moseley, V.
    Weber, R.
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2011, 47 : S15 - S15
  • [26] Mutator pathways unleashed by epigenetic silencing in human cancer
    Jacinto, Filipe V.
    Esteller, Manel
    MUTAGENESIS, 2007, 22 (04) : 247 - 253
  • [27] Validation of a model of colon cancer progression. (vol 192, pg 446, 2000)
    Hewitt, RE
    McMarlin, A
    Kleiner, D
    Wersto, R
    Martin, P
    Tsokos, M
    Stamp, GHW
    Stetler-Stevenson, WG
    JOURNAL OF PATHOLOGY, 2001, 194 (04): : 507 - 507
  • [28] Expression of Estrogen Receptor β in Colon Cancer Progression
    Castiglione, Francesca
    Taddei, Antonio
    Degl'Innocenti, Duccio Rossi
    Buccoliero, Anna Maria
    Bechi, Paolo
    Garbini, Francesca
    Chiara, Francesca Gheri
    Moncini, Daniela
    Cavallina, Giulia
    Marascio, Lavinia
    Freschi, Giancarlo
    Gian, Luigi Taddei
    DIAGNOSTIC MOLECULAR PATHOLOGY, 2008, 17 (04) : 231 - 236
  • [29] Epigenetic Mechanisms of Human Papillomavirus-Associated Head and Neck Cancer
    Anayannis, Nicole V. J.
    Schlecht, Nicolas F.
    Belbin, Thomas J.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2015, 139 (11) : 1373 - 1378
  • [30] Characterization of colon cancer-associated antigens that would be key therapeutic targets in the prevention of disease relapse or progression.
    Broussard, Elizabeth Kyungsun
    Coveler, Andrew L.
    Whiting, Samuel H.
    Kim, Rachel
    Rastetter, Lauren
    Gad, Ekram
    Higgins, Doreen
    Slota, Meredith
    Gyurkey, Grace
    Childs, Jennifer
    Disis, Mary Lenora
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
12345